imatinib mesylate has been researched along with Polyploid in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, JJ; Lin, DJ; Liu, Q; Long, ZJ; Lu, G; Luo, Y; Tu, XX; Wang, LX; Zheng, FM | 1 |
| DeLuca, TA; Duncan, MT; Kuo, HY; Miller, WM; Mrksich, M; Yi, M | 1 |
| Arai, A; Kurosu, T; Miura, O; Murakami, N; Oshikawa, G | 1 |
| Balabanov, S; Barett, C; Bokemeyer, C; Bosotti, R; Braig, M; Brümmendorf, TH; Gontarewicz, A; Holyoake, TL; Jost, E; Keller, G; Moll, J; Raddrizzani, L; Rohe, I | 1 |
4 other study(ies) available for imatinib mesylate and Polyploid
| Article | Year |
|---|---|
A novel compound against oncogenic Aurora kinase A overcomes imatinib resistance in chronic myeloid leukemia cells.
Topics: Antineoplastic Agents; Aurora Kinase A; Cell Cycle; Cell Differentiation; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Phosphorylation; Polyploidy; Pyrazoles; Pyrimidines | 2015 |
SIRT1 is a critical regulator of K562 cell growth, survival, and differentiation.
Topics: Autophagy; Cell Differentiation; Cell Lineage; Cell Proliferation; Cell Survival; Cytosol; Erythroid Cells; Gene Silencing; Histone Deacetylases; Humans; Imatinib Mesylate; K562 Cells; Megakaryocytes; Niacinamide; Polyploidy; Sirtuin 1; Tetradecanoylphorbol Acetate | 2016 |
Clonal evolution with double Ph followed by tetraploidy in imatinib-treated chronic myeloid leukemia with e19a2 transcript in transformation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Base Sequence; Benzamides; Bone Marrow; Cell Transformation, Neoplastic; Clone Cells; DNA Mutational Analysis; Female; Fusion Proteins, bcr-abl; Gene Expression Regulation, Leukemic; Humans; Imatinib Mesylate; In Situ Hybridization, Fluorescence; Karyotyping; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Molecular Sequence Data; Philadelphia Chromosome; Piperazines; Polyploidy; Pyrimidines; RNA, Messenger; RNA, Neoplasm; Time Factors | 2010 |
Abcg2 overexpression represents a novel mechanism for acquired resistance to the multi-kinase inhibitor Danusertib in BCR-ABL-positive cells in vitro.
Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Aurora Kinases; Benzamides; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Clone Cells; Drug Resistance, Neoplasm; Drug Synergism; Fusion Proteins, bcr-abl; Gene Expression Regulation, Leukemic; Hematopoietic Stem Cells; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mutation; Neoplasm Proteins; Oligonucleotide Array Sequence Analysis; Piperazines; Polyploidy; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Pyrazoles; Pyrimidines; Signal Transduction | 2011 |